<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000869.v1.p1" parentStudy="phs000869.v1.p1" createDate="2015-02-11" modDate="2015-04-01">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Multiple Principal Investigator</td><td>Thomas Vaughan, MD, MPH</td><td>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</td></tr>
		<tr><td>Multiple Principal Investigator</td><td>David C. Whiteman, PhD</td><td>Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia</td></tr>
		<tr><td>Funding Source</td><td>R01 CA136725</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Barrett&#39;s and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)</StudyNameEntrez>
	<StudyNameReportPage>Barrett&#39;s and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>BEAGESS is a genome-wide association study (GWAS) which takes advantage of the extensive data collected by investigators in the Barrett&#39;s and Esophageal Adenocarcinoma Consortium (BEACON, <a href="http://beacon.tlvnet.net/">http://beacon.tlvnet.net</a>), representing many of the high-quality population-based and other epidemiologic studies of BE and EA in the world. The overall goal of our research is to evaluate the influence of genetic susceptibility on risk of EA and its main precancerous condition, BE.</p> <p>The primary aims of the study are to identify tagSNPs most strongly associated with risk of esophageal adenocarcinoma (EA) and Barrett&#39;s esophagus (BE). In the secondary aims we will evaluate the extent to which the most significant associations vary according to key environmental and host factors for these conditions, including gender, obesity and cigarette smoking. These results will guide additional exploratory analyses examining ways in which individual SNP results might be aggregated to shed light in the importance of specific pathways relevant to the etiology of BE and EA, and to identify possible epistatic effects.</p>]]>
	</Description>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="24121790"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22961001"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24168968"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24943595"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25269698"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24530603"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25280564"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25447851"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Esophageal Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Barrett Esophagus"/>
	</Diseases>
	<Attributions>
		<Header title="Multiple Principal Investigator">
			<AttName>Thomas Vaughan, MD, MPH</AttName>
			<Institution>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Multiple Principal Investigator">
			<AttName>David C. Whiteman, PhD</AttName>
			<Institution>Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01 CA136725</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects"/>
		<ConsentGroup groupNum="1" shortName="GRU-MDS" longName="General Research Use (MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000869.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000869.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet/>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use (MDS)</ConsentName>
        <ConsentAbbrev>GRU-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification. Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
